Name and surname:
|
doc. MUDr. Michal Chovanec, PhD.
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
associate professor | Comenius University, Faculty of Medicine | since 2015 |
fellow, oncologist | National Cancer Institute | 2008 - now |
research scholar | Indiana University Melvin and Brenn Cancer Center, Indianapolis, IN, USA | 2016-2017 |
visiting professor | Indiana University Melvin and Brenn Cancer Center, Indianapolis, IN, USA | 2017-present |
IV.a - Activity description, course name, other | IV.b - Name of the institution | IV.c - Year |
---|---|---|
11th Masterclass in Clinical Oncology | European School of Oncology | 2011 |
board examination clinical oncology | Comenius University, Faculty of Medicine | 2013 |
ICRETT fellowship | Union for International Cancer Control - Indiana University Melvin and Brenn Cancer Center, Indianapolis, IN, USA | 2015 |
Methods in Clinical Cancer Research | European Organisation for Research and Treatment of Cancer and American Association for Cancer Research - Zeist, Netherlands | 2019 |
V.1.a - Name of the profile course | V.1.b - Study programme | V.1.c - Degree | V.1.d - Field of study |
---|---|---|---|
oncology | general medicine | I.+II. | general medicine |
V.5.a - Name of the course | V.5.b - Study programme | V.5.c - Degree | V.5.d - Field of study |
---|---|---|---|
Socially significant malignancies | general medicine | I.+II. | general medicine |
Chovanec M, Cheng L. Advances in diagnosis and treatment of testicular cancer. BMJ. 2022 Nov 28;379:e070499. doi: 10.1136/bmj-2022-070499. PMID: 36442868. IF(JCR) 105,7
Chovanec M, Abu Zaid M, Hanna N, El-Kouri N, Einhorn LH, Albany C. Long-term toxicity of cisplatin in germ-cell tumor survivors. Ann Oncol. 2017 Nov 1;28(11):2670-2679. doi: 10.1093/annonc/mdx360. PMID: 29045502; PMCID: PMC6246726. IF (JCR) 2017=13,926
Chovanec M, Adra N, Abu Zaid M, Abonour R, Einhorn L. High-dose chemotherapy for relapsed testicular germ cell tumours. Nat Rev Urol. 2023 Apr;20(4):217-225. doi: 10.1038/s41585-022-00683-1. Epub 2022 Dec 7. PMID: 36477219 IF (JCR) 2023 = 12,1
Chovanec M, Cierna Z, Miskovska V, Machalekova K, Kalavska K, Rejlekova K, Svetlovska D, Macak D, Spanik S, Kajo K, Babal P, De Giorgi U, Mego M, Mardiak J. Systemic immune-inflammation index in germ-cell tumours. Br J Cancer. 2018 Mar 20;118(6):831-838. doi: 10.1038/bjc.2017.460. Epub 2018 Feb 27. PMID: 29485980; PMCID: PMC5877428. IF (JCR) 2018=5,416
Chovanec M, Lauritsen J, Bandak M, Oing C, Kier GG, Kreiberg M, Rosenvilde J, Wagner T, Bokemeyer C, Daugaard G. Late adverse effects and quality of life in survivors of testicular germ cell tumour. Nat Rev Urol. 2021 Apr;18(4):227-245. doi: 10.1038/s41585-021-00440-w. Epub 2021 Mar 8. PMID: 33686290. IF (JCR) 2020=14,432
Chovanec M, Cheng L. Advances in diagnosis and treatment of testicular cancer. BMJ. 2022 Nov 28;379:e070499. doi: 10.1136/bmj-2022-070499. PMID: 36442868. IF(JCR) 105,7
Orszaghova Z, Svetlovska D, Vasilkova L, Lesko P, Sycova-Mila Z, Obertova J, Palacka P, Rejlekova K, Remenarova V, Kalavska K, Mladosievicova B, Mardiak J, Mego M, Chovanec M. Longitudinal Assessment of Cognitive Function in Survivors of Testicular Germ Cell Tumor. Eur Urol Oncol. 2025 Apr;8(2):460-468. doi: 10.1016/j.euo.2024.12.003. Epub 2024 Dec 18. PMID: 39701870. IF (JCR) 2020= 8,3
Chovanec M, Lauritsen J, Bandak M, Oing C, Kier GG, Kreiberg M, Rosenvilde J, Wagner T, Bokemeyer C, Daugaard G. Late adverse effects and quality of life in survivors of testicular germ cell tumour. Nat Rev Urol. 2021 Apr;18(4):227-245. doi: 10.1038/s41585-021-00440-w. Epub 2021 Mar 8. PMID: 33686290. IF (JCR) 2020=14,432
Chovanec M, Kalavska K, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Orszaghova Z, Lesko P, De Angelis V, Vasilkova L, Svetlovska D, Mladosievicova B, Mardiak J, Pastorek M, Vlkova B, Celec P, Mego M. Cognitive impairment and biomarkers of gut microbial translocation in testicular germ cell tumor survivors. Front Oncol. 2023 Mar 21;13:1146032. doi: 10.3389/fonc.2023.1146032. PMID: 37025582; PMCID: PMC10070731. IF (JCR) 6,575
Chovanec M, Adra N, Abu Zaid M, Abonour R, Einhorn L. High-dose chemotherapy for relapsed testicular germ cell tumours. Nat Rev Urol. 2023 Apr;20(4):217-225. doi: 10.1038/s41585-022-00683-1. Epub 2022 Dec 7. PMID: 36477219. IF (JCR) 15,3
Chovanec M, Hanna N, Cary KC, Einhorn L, Albany C. Management of stage I testicular germ cell tumours. Nat Rev Urol. 2016 Nov;13(11):663-673. doi: 10.1038/nrurol.2016.164. Epub 2016 Sep 13. PMID: 27618772. IF (JCR) 2016=7,735 CITATION: Gilligan, T. - Lin, D.W. - Aggarwal, R. - Chism, D. - Cost, N. - Derweesh, I.H. - Emamekhoo, H. - Feldman, D.R. - Geynisman, D.M. - Hancock, S.L. - LaGrange, C. - Levine, E.G. - Longo, T. - Lowrance, W. - McGregor, B. - Monk, P. -Picus, J. - Pierorazio, P. - Rais-Bahrami, S. - Saylor, P. - Sircar, K. - Smith, D.C. - Tzou, K. - Vaena, D. - Vaughn, D. - Yamoah, K. - Yamzon, J. - Johnson-Chilla, A. - Keller, J. - Pluchino, L.A.: JNCCN Journal of the National Comprehensive CancerNetwork, vol. 17, no. 12, 2019, s. 1529-1554 - SCI ; SCOPUS
Chovanec M, Abu Zaid M, Hanna N, El-Kouri N, Einhorn LH, Albany C. Long-term toxicity of cisplatin in germ-cell tumor survivors. Ann Oncol. 2017 Nov 1;28(11):2670-2679. doi: 10.1093/annonc/mdx360. PMID: 29045502; PMCID: PMC6246726. IF (JCR) 2017=13,926 CITATION: Gilligan, T. - Lin, D.W. - Aggarwal, R. - Chism, D. - Cost, N. - Derweesh, I.H. - Emamekhoo, H. - Feldman, D.R. - Geynisman, D.M. - Hancock, S.L. - LaGrange, C. - Levine, E.G. - Longo, T. - Lowrance, W. - McGregor, B. - Monk, P. -Picus, J. - Pierorazio, P. - Rais-Bahrami, S. - Saylor, P. - Sircar, K. - Smith, D.C. - Tzou, K. - Vaena, D. - Vaughn, D. - Yamoah, K. - Yamzon, J. - Johnson-Chilla, A. - Keller, J. - Pluchino, L.A.: JNCCN Journal of the National Comprehensive CancerNetwork, vol. 17, no. 12, 2019, s. 1529-1554 - SCI ; SCOPUS
Chovanec M, Abu Zaid M, Hanna N, El-Kouri N, Einhorn LH, Albany C. Long-term toxicity of cisplatin in germ-cell tumor survivors. Ann Oncol. 2017 Nov 1;28(11):2670-2679. doi: 10.1093/annonc/mdx360. PMID: 29045502; PMCID: PMC6246726. IF (JCR) 2017=13,926 CITATION: Stephenson, A. - Eggener, S.E. - Bass, E.B. - Chelnick, D.M. - Daneshmand, S. - Feldman, D. - Gilligan, T. - Karam, J.A. - Leibovich, B. - Liauw, S.L. - Masterson, T.A. - Meeks, J.J. -Pierorazio, P.M. - Sharma, R. - Sheinfeld, J.: Journal of Urology, vol. 202, no. 2, 2019, s. 272-281 - SCI ; SCOPUS
Chovanec M, Vasilkova L, Setteyova L, Obertova J, Palacka P, Rejlekova K, Sycova-Mila Z, Kalavska K, Svetlovska D, Cingelova S, Mladosievicova B, Mardiak J, Mego M. Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors. Oncologist. 2018 May;23(5):617-623. doi: 10.1634/theoncologist.2017-0457. Epub 2018 Jan 19. PMID: 29352051; PMCID: PMC5947452. IF (JCR) 2018=5,252 CITATION: Fung, C. - Dinh, P.C. - Fossa, S.D. - Travis, L.B.: Journal of the National Comprehensive Cancer Network, vol. 17, no. 12, 2019, s. 1557-1568 -
SCI ; SCOPUS
Chovanec M, Cierna Z, Miskovska V, Machalekova K, Kalavska K, Rejlekova K, Svetlovska D, Macak D, Spanik S, Kajo K, Babal P, De Giorgi U, Mego M, Mardiak J. Systemic immune-inflammation index in germ-cell tumours. Br J Cancer. 2018 Mar 20;118(6):831-838. doi: 10.1038/bjc.2017.460. Epub 2018 Feb 27. PMID: 29485980; PMCID: PMC5877428. IF (JCR) 2018=5,416 CITATION: Albany, C.: British Journal of Cancer, vol. 118, no. 6, 2018, s. 761-762 - SCI ; SCOPUS
2016-2029 Agentúra pre podpory výskumu a vývoja - APVV-15-0086 - Identifikácia biomarkerov asociovaných s neskorou toxicitou chemoterapie u germinatívnych nádorov testis - zodpovedný riešiteľ / principal investigator
2019 - 2024 - Agentúra pre podpory výskumu a vývoja - APVV-19-0411 - Identifikácia a validácia biomarkerov a zodpovedných molekulárnych dráh neskorej toxicity kuratívnej liečby u germinatívnych nádorov testis - zodpovedný riešiteľ / principal investigator
2018 - 2021 - MZ SR 2018/39-LFUK-13.Prekonanie rezistencie voči cisplatine u refraktérnych testikulárnych nádorov zo zárodočných buniek prostredníctvom terapie nasmerovanej voči markerom nádorových kmeňových buniek - zodpovedný riešiteľ / principal investigator
2019 - 2021 - Grant VEGA 1/0327/19. Identifikácia úlohy mikrobiómu a imunitných molekulárnych mechanizmov kognitínych dysfunkcií následkom neskorej toxicity liečby u germinatívnych nádorov testis. Zodpovedný riešiteľ: MUDr. Chovanec Michal, PhD. - zodpovedný riešiteľ / principal investigator
R4 Fellowship for Excellent Researcher [09I03-03-V04-00248]; Long-term cognitive impairment and underlying molecular mechanisms in testicular germ-cell tumor survivors - zodpovedný riešiteľ/principal investigator
VII.a - Activity, position | VII.b - Name of the institution, board | VII.c - Duration |
---|---|---|
journal editor | BMC Cancer, Springer Nature, IF 4,430; indexovaný v CC, Web of Science, SCOPUS, PubMed https://bmccancer.biomedcentral.com | 2019 - present |
journal editor | Klinická onkologie, indexed in Web of Science, SCOPUS, PubMed | 2024 - present |
VIII.a - Name of the institution | VIII.b - Address of the institution | VIII.c - Duration (indicate the duration of stay) | VIII.d - Mobility scheme, employment contract, other (describe) |
---|---|---|---|
European School of Oncology | Piazza Indipendenza, 2 6500 Bellinzona, Switzerland | 2011 | Masterclass in oncology |
European Organisation for Research and Treatment of Cancer and American Association for Cancer Research - Zeist, Netherlands | EORTC Headquarters, Brussels, Belgium 615 Chestnut St., 17th Floor Philadelphia, PA 19106-4404 | 2019 | Methods in Clinical Cancer Research |
Indiana University Melvin and Brenn Cancer Center, Indianapolis, IN, USA | 35 Barnhill Drive, 46202, Indianapolis, IN, USA | 2015 | UICC ICRETT Fellowship |
Indiana University Melvin and Brenn Cancer Center, Indianapolis, IN, USA | 535 Barnhill Drive, 46202, Indianapolis, IN, USA | 2016-2017 | research scholar |
Indiana University Melvin and Brenn Cancer Center, Indianapolis, IN, USA | 535 Barnhill Drive, 46202, Indianapolis, IN, USA | 2017 - present | visiting professor |
EORTC Quality if life group | Bruselles, Belgium | 2023 - present | European consortium for organisation of cancer research |
EORTC Genitourinary cancers working group | Bruselles, Belgium | 2023 - present | European consortium for organisation of cancer research |
• 2014 - prize for best case repost - Klinická onkologie 2014
• 2016 - Competition of young oncologists – Foundation for cancer research, 2nd in postdoc category
• 2017 - Testicular Cancer Research in Slovakia, invited lecture, Indiana University Simon Cancer Center, Indianapolis, Indiana, USA
• 2018 - Conquer Cancer Foundation of American Society of Clinical Oncology (ASCO) Merit Award for exceptional work of young researcher, oral presentation, Genitourinary Cancers Symposium, San Francisco, California, USA
• 2018 - Competition of young oncologists – Foundation for cancer research, 1st in postdoc category
• 2018 - The Union for International Cancer Control (UICC) – selected for case study: Fighting Testicular Cancer in Slovakia Through Clinical and Translational studies – Spotlight on Quality Treatment and Care by Michal Chovanec, https://www.uicc.org/resources/case-study-fighting-testicular-cancer-slovakia-through- clinical-and-translational-research
• 2018 - Immune Mechanisms and Possible Immune Therapy in Testicular Germ Cell Tumours – Invited Lecture, 9th Copenhagen Workshop on Testicular Germ Cell Cancer, Kodaň, Dánsko
• 2018 - Personality of science and technology up to 35 years old in 2018, award of Ministry of education, science, reseatch and sport of Slovak Republic
• 2024 - European Testicular Tumor Workshop, Prague - organising committee
• 2025 - Therapeutiv options in testis cancer therapies and their late consequences - Vyzvaná prednáška, ASA/ICA annual meeting of American and International Society of Andrology, Washington D.C., USA